how long have glp-1 been on the market Industry Trends and Global Forecasts 2024-2035: Over 150 GLP-1 Drug Candidates in Development for Multiple Indications, Type 2 Diabetes and Obesity Drive GLP-1 Drug Development Boom GLP-1 Receptor Agonist Market Growth

(KFF) What Are GLP-1 Drugs Really

A number of studies support the use of GLP-1 for weight loss

However, Rybelsus may lead to greater weight loss (8-11% body weight reduction) compared to Trulicity (3-5%), while Trulicity has specific FDA approval for cardiovascular risk reduction in adults with established cardiovascular disease or multiple cardiovascular risk factors

Additionally, if you experience symptoms of thyroid tumorssuch as a lump in the neck, persistent hoarseness, difficulty swallowing, or shortness of breathcontact your provider for evaluation, though it should be noted that the clinical significance of thyroid findings from animal studies remains uncertain in humans

Once monthly appointments are scheduled with our medical provider to monitor the dosage and your weight loss goals